Back to Search
Start Over
The effect of potential therapeutic agents on QT interval in patients with COVID-19 Infection: The importance of close monitoring and correction of electrolytes.
- Source :
-
Medical hypotheses [Med Hypotheses] 2020 Oct; Vol. 143, pp. 109847. Date of Electronic Publication: 2020 May 16. - Publication Year :
- 2020
-
Abstract
- Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Subjects :
- Antiviral Agents pharmacology
COVID-19
Coronavirus Infections blood
Drug Combinations
Drug Monitoring
Heart Conduction System drug effects
Humans
Hydroxychloroquine pharmacology
Hypokalemia drug therapy
Hypokalemia physiopathology
Long QT Syndrome blood
Long QT Syndrome prevention & control
Lopinavir pharmacology
Magnesium blood
Magnesium therapeutic use
Pneumonia, Viral blood
Potassium blood
Potassium therapeutic use
Retrospective Studies
Ritonavir pharmacology
SARS-CoV-2
COVID-19 Drug Treatment
Antiviral Agents adverse effects
Betacoronavirus
Coronavirus Infections drug therapy
Hydroxychloroquine adverse effects
Hypokalemia chemically induced
Long QT Syndrome chemically induced
Lopinavir adverse effects
Pandemics
Pneumonia, Viral drug therapy
Ritonavir adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1532-2777
- Volume :
- 143
- Database :
- MEDLINE
- Journal :
- Medical hypotheses
- Publication Type :
- Academic Journal
- Accession number :
- 32460209
- Full Text :
- https://doi.org/10.1016/j.mehy.2020.109847